1. Home
  2. SGU vs VSTM Comparison

SGU vs VSTM Comparison

Compare SGU & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGU

Star Group L.P.

HOLD

Current Price

$12.86

Market Cap

410.0M

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$4.76

Market Cap

470.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGU
VSTM
Founded
1995
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.0M
470.7M
IPO Year
1997
2011

Fundamental Metrics

Financial Performance
Metric
SGU
VSTM
Price
$12.86
$4.76
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.50
AVG Volume (30 Days)
22.3K
2.2M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
5.90%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$1,784,418,000.00
$30,914,000.00
Revenue This Year
N/A
$282.64
Revenue Next Year
N/A
$72.25
P/E Ratio
$6.70
N/A
Revenue Growth
1.04
209.14
52 Week Low
$11.31
$4.01
52 Week High
$13.53
$11.25

Technical Indicators

Market Signals
Indicator
SGU
VSTM
Relative Strength Index (RSI) 50.63 36.30
Support Level $12.31 N/A
Resistance Level $12.99 $6.79
Average True Range (ATR) 0.34 0.38
MACD 0.01 -0.14
Stochastic Oscillator 39.84 15.24

Price Performance

Historical Comparison
SGU
VSTM

About SGU Star Group L.P.

Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: